Summary
Serum samples collected from patients with a wide variety of diseases from African and other countries were tested for antibodies to the human spumaretrovirus (HSRV). A spumaviralenv-specific ELISA was employed as screening test. Out of 3020 human sera screened, 106 were found to be positive (3.2%). While the majority of patients' sera from Europe (1581) were negative, 26 were positive (1.6%). Sera from healthy adult blood donors (609), from patients with multiple sclerosis (48), Graves' disease (45), and chronic fatigue syndrome (41) were negative or showed a very low prevalence for spumaviralenv antibodies. A higher percentage of seropositives (6.3%) were found among 1338 African patients from Tanzania, Kenya, and Gabon. Out of 1180 patients from Tanzania, 708 suffered from tumors, 75 from AIDS, and 128 had gynecological problems; 51 of the Tanzanian patients were HSRV seropositive (4.3%). A particularly high percentage of 16.6% seropositives were identified among nasopharyngeal carcinoma patients (NPC) from Kenya and Tanzania consistent with results reported 10 years ago. However, 20 nasopharyngeal carcinoma patients from Malaysia were HSRV-seronegative. In selected cases, sera from seropositive individuals were reacted with proteins from HSRV-infected cells in vitro. HSRVenv-andgag-specific antibodies were specifically detected by these sera in Western blots.
The results indicate spumavirus infections in human patients with various diseases at a relatively low prevalence worldwide; in African patients, however, the prevalence of spumavirus infections is markedly higher.
Similar content being viewed by others
References
Achong BG, Mansell PWA, Epstein MA, Clifford P (1971) An unusual virus in cultures from a human nasopharyngeal carcinoma. J Natl Cancer Inst 42: 299–307
Achong BG, Epstein MA (1978) Preliminary seroepidemiological studies on the human syncytial virus. J Gen Virol 40: 175–181
Ciampolillo A, Marini V, Mirakian R, Buscema M, Schulz T, Pujol-Borrell R, Botazzo GF (1989) Retrovirus-like sequences in Graves' disease: implications for human autoimmunity. Lancet i: 1096–1100
Coffin JM (1990) Retroviridae and their replication. In: Fields BN, Knipe DM (eds) Virology, 2nd edn. Raven Press, New York, pp 1437–1500
Cullen BR (1991) Human immunodeficiency virus as a prototypic complex retrovirus. J Virol 65: 1053–1056
Flügel RM, Rethwilm A, Maurer B, Darai G (1987) Nucleotide sequence analysis of the env gene and its flanking regions reveal two novel genes. EMBO J 6: 2077–2084
Flügel RM (1991) Spumaviruses: a group of complex retroviruses. J Acquir Immune Defic Syndr 4: 739–750
Harlow E, Lane D (1988) Immunoblotting. In: Harlow E, Lane D (eds) Antibodies — a laboratory manual, 1st edn. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 471–509
Hooks JJ, Detrick-Hooks B (1981) Spumavirinae: foamy virus group infections: comparative aspects and diagnosis. In: Kurstak E, Kurstak C (eds) Comparative diagnosis of viral diseases. Academic Press, New York, pp 599–617
Hunsmann G, Flügel RM, Walder R (1990) Retroviral antibodies in Indians. Nature 345: 120
Keller A, Partin KM, Löchelt M, Bannert H, Flügel RM, Cullen BR (1991) Characterization of the transcriptional trans-activator of human foamy retrovirus. J Virol 65: 2589–2594
Komaroff AL (1988) Chronic fatigue syndrome: relationship to chronic viral infection. J Virol Methods 21: 3–10
Löchelt M, Zentgraf H, Flügel RM (1991) Construction of an infectious of the full-lenght human spumaretrovirus genome and mutagenesis of the bel 1 gene. Virology 184: 43–54
Loh PC, Matsuura F, Mizumoto C (1980) Seroepidemiology of human syncytial virus: antibody prevalence in the Pacific. Intervirology 13: 87–90
Mahnke C, Löchelt M, Bannert H, Flügel RM (1990) Specific enzyme-linked immunosorbent assay for the detection of antibodies to the human spumaretrovirus. J Virol Meth 29: 13–22
Maurer B, Bannert H, Darai G, Flügel RM (1988) Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus. J Virol 62: 1590–1597
Muller HK, Ball G, Epstein MA, Achong BG, Lenoir G, Levin A (1980) The prevalence of naturally occurring antibodies to human syncytial virus in East African populations. J Gen Virol 47: 399–406
Muranyi W, Flügel RM (1991) Analysis of splicing patterns of human spumaretrovirus by polymerase chain reaction reveals complex RNA structures. J Virol 65: 727–735
Netzer KO, Rethwilm A, Maurer B, ter Meulen V (1990) Identification of the major immunogenic structural proteins of human foamy virus. J Gen Virol 71: 1237–1241
Neumann-Haefelin D, Rethwilm A, Bauer G, Gudat F, zur Hausen H (1983) Characterization of a foamy virus isolated fromCercopithecus aethiops lymphoblastoid cells. Med Microbiol Immunol 172: 75–86
Pinter A, Honnen WJ, Tilley SA, Bona C, Zaghouani H, Corny M, Zolla-Pazner S (1989) Oligomeric structure of gp 41, the transmembrane protein of human immunodeficiency virus type 1. J Virol 63: 2674–2679
Rethwilm A, Darai G, Rösen A, Maurer B, Flügel RM (1979) Molecular cloning of the genome of human spumaretrovirus. Gene 59: 19–28
Rethwilm A, Erlwein O, Baunach G, Maurer B, ter Meulen V (1991) The transcriptional transactivator of human foamy virus maps to the bel 1 genomic region. Proc Natl Acad Sci USA 88: 941–945
Tobaly-Tapiero J, Santillana-Hayat M, Giron ML, Guillemin MC, Rozain F, Peries J, Emanoil-Ravier R (1990) Molecular differences between two immunologically related spumaretroviruses: the human prototype HSRV and the chimpanzee isolate SFV 6. AIDS Res Hum Retrovir 6: 951–957
Weiss RA, Teich N, Varmus HE, Coffin JM (eds) (1985) RNA tumor viruses, 2nd edn. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 25–207
Weiss RA (1988) A virus in search of a disease. Nature 333: 497–498
Werner J, Gelderblom H (1979) Isolation of foamy virus from patients with de Quervain thyroiditis. Lancet ii: 258–259
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mahnke, C., Kashaiya, P., Rössler, J. et al. Human spumavirus antibodies in sera from African patients. Archives of Virology 123, 243–253 (1992). https://doi.org/10.1007/BF01317261
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01317261